News | April 28, 2010

Imaging Company Begins Shift to Interventional Devices

April 28, 2010 – Deviating from its focus on intravascular imaging systems and fractional flow reserve (FFR) catheters, Volcano Corp. said yesterday it entered into a Japanese distribution agreement with AngioScore for its AngioSculpt PTCA scoring balloon catheter. This is the first of what Volcano believes will be many products distributed by Volcano Japan.

This relationship combines Volcano’s intravascular ultrasound (IVUS) visualization with the AngioSculpt to provide precision-guided therapy. The use of IVUS has already taken hold in Japan, where the technique is used in more than 70 percent of all percutaneous coronary interventions (PCI).

Over the past 18 months, Volcano has built a direct sales force in Japan. The exclusive, five-year distribution agreement became effective April 1. Volcano will distribute the entire line of AngioSculpt catheters and any new, modified or next-generation products.

Volcano is also developing is own angioplasty balloon, which is integrated with an IVUS catheter. The company hopes to launch the product by the end of 2010 and said it will be the first of several interventional therapy/visualization tools it plans to release.

For more information: www.volcanocorp.com, www.angioscore.com

Related Content

Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018
Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k...
Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions
News | Balloon Catheter | January 24, 2018
Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product portfolio. CSI is...
Abbott recalls its NC Balloon catheters
News | Balloon Catheter | May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter | November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter | January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter | October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni
Overlay Init